3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
6
Urinary Bladder Neoplasms
2
Recurrence
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Penile Neoplasms
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neuroendocrine Tumors
1
Lymphoma
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Brain Neoplasms
1
Anus Neoplasms
1
Anatomic Stage III Breast Cancer AJCC v8
1
Interventions
Cyclophosphamide
7
Etoposide
5
Prednisone
4
Doxorubicin
4
Vincristine
3
romidepsin
2
pembrolizumab
2
etoposide phosphate
2
duvelisib
2
Melphalan
2
Brentuximab Vedotin
2
Azacitidine
2
10-propargyl-10-deazaaminopterin
2
tazemetostat
1
sodium-iodide symporter
1
ruxolitinib
1
prednylidene
1
glofitamab
1
fludarabine phosphate
1
fludarabine
1
deltacortene
1
cemiplimab
1
brincidofovir
1
belinostat
1
X-Rays
1
Whole-Body Irradiation
1
Valganciclovir
1
Therapeutics
1
Tacrolimus
1
Specimen Handling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immunoblastic Lymphadenopathy
×
entinostat
×
1 year
×
Clear all
No trials found.